Nutritional issues in patients with obesity and cirrhosis
|
摘要
Obesity and metabolic syndrome are considered as responsible for a condition known as the non-alcoholic fatty liver disease that goes from simple accumulation of triglycerides to hepatic inflammation and may progress to cirrhosis.Patients with obesity also have an increased risk of primary liver malignancies and increased body mass index is a predictor of decompensation of liver cirrhosis.Sarcopenic obesity confers a risk of physical impairment and disability that is significantly higher than the risk induced by each of the two conditions alone as it has been shown to be an independent risk factor for chronicliver disease in patients with obesity and a prognostic negative marker for the evolution of liver cirrhosis and the results of liver transplantation.Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble,water-soluble vitamins and trace elements and should be supplemented appropriately.Diet,physical activity and protein intake should be carefully monitored in these fragile patients according to recent recommendations.Bariatric surgery is sporadically used in patients with morbid obesity and cirrhosis also in the setting of liver transplantation.The risk of sarcopenia,micronutrient status,and the recommended supplementation in patients with obesity and cirrhosis are discussed in this review.Furthermore,the indications and contraindications of bariatric surgery-induced weight loss in the cirrhotic patient with obesity are discussed.
Obesity and metabolic syndrome are considered as responsible for a condition known as the non-alcoholic fatty liver disease that goes from simple accumulation of triglycerides to hepatic inflammation and may progress to cirrhosis.Patients with obesity also have an increased risk of primary liver malignancies and increased body mass index is a predictor of decompensation of liver cirrhosis.Sarcopenic obesity confers a risk of physical impairment and disability that is significantly higher than the risk induced by each of the two conditions alone as it has been shown to be an independent risk factor for chronicliver disease in patients with obesity and a prognostic negative marker for the evolution of liver cirrhosis and the results of liver transplantation.Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble,water-soluble vitamins and trace elements and should be supplemented appropriately.Diet,physical activity and protein intake should be carefully monitored in these fragile patients according to recent recommendations.Bariatric surgery is sporadically used in patients with morbid obesity and cirrhosis also in the setting of liver transplantation.The risk of sarcopenia,micronutrient status,and the recommended supplementation in patients with obesity and cirrhosis are discussed in this review.Furthermore,the indications and contraindications of bariatric surgery-induced weight loss in the cirrhotic patient with obesity are discussed.
Obesity and metabolic syndrome are considered as responsible for a condition known as the non-alcoholic fatty liver disease that goes from simple accumulation of triglycerides to hepatic inflammation and may progress to cirrhosis.Patients with obesity also have an increased risk of primary liver malignancies and increased body mass index is a predictor of decompensation of liver cirrhosis.Sarcopenic obesity confers a risk of physical impairment and disability that is significantly higher than the risk induced by each of the two conditions alone as it has been shown to be an independent risk factor for chronicliver disease in patients with obesity and a prognostic negative marker for the evolution of liver cirrhosis and the results of liver transplantation.Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble,water-soluble vitamins and trace elements and should be supplemented appropriately.Diet,physical activity and protein intake should be carefully monitored in these fragile patients according to recent recommendations.Bariatric surgery is sporadically used in patients with morbid obesity and cirrhosis also in the setting of liver transplantation.The risk of sarcopenia,micronutrient status,and the recommended supplementation in patients with obesity and cirrhosis are discussed in this review.Furthermore,the indications and contraindications of bariatric surgery-induced weight loss in the cirrhotic patient with obesity are discussed.
引文
1 Kleiner DE,Brunt EM,Van Natta M,Behling C,Contos MJ,Cummings OW,Ferrell LD,Liu YC,Torbenson MS,Unalp-Arida A,Yeh M,Mc Cullough AJ,Sanyal AJ;Nonalcoholic Steatohepatitis Clinical Research Network.Design and validation of a histological scoring system for nonalcoholic fatty liver disease.Hepatology2005;41:1313-1321[PMID:15915461 DOI:10.1002/hep.20701]
2 Welzel TM,Graubard BI,Zeuzem S,El-Serag HB,Davila JA,Mc Glynn KA.Metabolic syndrome increases the risk of primary liver cancer in the United States:a study in the SEER-Medicare database.Hepatology 2011;54:463-471[PMID:21538440 DOI:10.1002/hep.24397]
3 Starley BQ,Calcagno CJ,Harrison SA.Nonalcoholic fatty liver disease and hepatocellular carcinoma:a weighty connection.Hepatology 2010;51:1820-1832[PMID:20432259 DOI:10.1002/hep.23594]
4 Ascha MS,Hanouneh IA,Lopez R,Tamimi TA,Feldstein AF,Zein NN.The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.Hepatology 2010;51:1972-1978[PMID:20209604 DOI:10.1002/hep.23527]
5 Chalasani N,Younossi Z,Lavine JE,Diehl AM,Brunt EM,Cusi K,Charlton M,Sanyal AJ.The diagnosis and management of nonalcoholic fatty liver disease:practice Guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology,and the American Gastroenterological Association.Hepatology 2012;55:2005-2023[PMID:22488764 DOI:10.1002/hep.25762]
6 Angulo P.Long-term mortality in nonalcoholic fatty liver disease:is liver histology of any prognostic significance?Hepatology 2010;51:373-375[PMID:20101746 DOI:10.1002/hep.23521]
7 Raynard B,Balian A,Fallik D,Capron F,Bedossa P,Chaput JC,Naveau S.Risk factors of fibrosis in alcohol-induced liver disease.Hepatology 2002;35:635-638[PMID:11870378 DOI:10.1053/jhep.2002.31782]
8 Ortiz V,Berenguer M,Rayón JM,Carrasco D,Berenguer J.Contribution of obesity to hepatitis C-related fibrosis progression.Am J Gastroenterol 2002;97:2408-2414[PMID:12358265 DOI:10.1111/j.1572-0241.2002.05995.x]
9 Bellentani S,Saccoccio G,Masutti F,CrocèLS,Brandi G,Sasso F,Cristanini G,Tiribelli C.Prevalence of and risk factors for hepatic steatosis in Northern Italy.Ann Intern Med 2000;132:112-117[PMID:10644271 DOI:10.7326/0003-4819-132-2-200001180-00029]
10 Ekstedt M,Franzén LE,Holmqvist M,Bendtsen P,Mathiesen UL,Bodemar G,Kechagias S.Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.Scand J Gastroenterol 2009;44:366-374[PMID:19016382 DOI:10.1080/00365520802555991]
11 Liu B,Balkwill A,Reeves G,Beral V;Million Women Study Collaborators.Body mass index and risk of liver cirrhosis in middle aged UK women:prospective study.BMJ 2010;340:c912[PMID:20223875 DOI:10.1136/bmj.c912]
12 Everhart JE,Lok AS,Kim HY,Morgan TR,Lindsay KL,Chung RT,Bonkovsky HL,Ghany MG;HALT-C Trial Group.Weightrelated effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.Gastroenterology 2009;137:549-557[PMID:19445938 DOI:10.1053/j.gastro.2009.05.007]
13 Berzigotti A,Abraldes JG.Impact of obesity and insulin-resistance on cirrhosis and portal hypertension.Gastroenterol Hepatol 2013;36:527-533[PMID:23731977 DOI:10.1016/j.gastrohep.2013.03.005]
14 Berzigotti A,Albillos A,Villanueva C,GenescáJ,Ardevol A,Augustín S,Calleja JL,Ba?ares R,García-Pagán JC,Mesonero F,Bosch J;Ciberehd Sport Diet Collaborative Group.Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity:The Sport Diet study.Hepatology2017;65:1293-1305[PMID:27997989 DOI:10.1002/hep.28992]
15 Ayala R,Grande S,Bustelos R,Ribera C,García-Sesma A,Jimenez C,Moreno E,Martínez-López J.Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients.BMC Gastroenterol 2012;12:114[PMID:22909075 DOI:10.1186/1471-230X-12-114]
16 Allman-Farinelli MA.Obesity and venous thrombosis:a review.Semin Thromb Hemost 2011;37:903-907[PMID:22198855 DOI:10.1055/s-0031-1297369]
17 La Mattina JC,Foley DP,Fernandez LA,Pirsch JD,Musat AI,D’Alessandro AM,Mezrich JD.Complications associated with liver transplantation in the obese recipient.Clin Transplant 2012;26:910-918[PMID:22694047 DOI:10.1111/j.1399-0012.2012.01669.x]
18 Cruz-Jentoft AJ,Baeyens JP,Bauer JM,Boirie Y,Cederholm T,Landi F,Martin FC,Michel JP,Rolland Y,Schneider SM,TopinkováE,Vandewoude M,Zamboni M;European Working Group on Sarcopenia in Older People.Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People.Age Ageing 2010;39:412-423[PMID:20392703 DOI:10.1093/ageing/afq034]
19 Rolland Y,Lauwers-Cances V,Cristini C,Abellan van Kan G,Janssen I,Morley JE,Vellas B.Difficulties with physical function associated with obesity,sarcopenia,and sarcopenic-obesity in community-dwelling elderly women:the EPIDOS(EPIDemiologie de l’OSteoporose)Study.Am J Clin Nutr 2009;89:1895-1900[PMID:19369381 DOI:10.3945/ajcn.2008.26950]
20 Koster A,Ding J,Stenholm S,Caserotti P,Houston DK,Nicklas BJ,You T,Lee JS,Visser M,Newman AB,Schwartz AV,Cauley JA,Tylavsky FA,Goodpaster BH,Kritchevsky SB,Harris TB;Health ABC study.Does the amount of fat mass predict age-related loss of lean mass,muscle strength,and muscle quality in older adults?JGerontol A Biol Sci Med Sci 2011;66:888-895[PMID:21572082DOI:10.1093/gerona/glr070]
21 Beavers KM,Hsu FC,Houston DK,Beavers DP,Harris TB,Hue TF,Kim LJ,Koster A,Penninx BW,Simonsick EM,Strotmeyer ES,Kritchevsky SB,Nicklas BJ;Health ABC Study.The role of metabolic syndrome,adiposity,and inflammation in physical performance in the Health ABC Study.J Gerontol A Biol Sci Med Sci2013;68:617-623[PMID:23109678 DOI:10.1093/gerona/gls213]
22 European Association for the Study of the Liver(EASL),European Association for the Study of Diabetes(EASD),European Association for the Study of Obesity(EASO).EASL-EASD-EASOClinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.Obes Facts 2016;9:65-90[PMID:27055256DOI:10.1159/000443344]
23 Tovo CV,Fernandes SA,Buss C,de Mattos AA.Sarcopenia and non-alcoholic fatty liver disease:Is there a relationship?A systematic review.World J Hepatol 2017;9:326-332[PMID:28293382 DOI:10.4254/wjh.v9.i6.326]
24 Hong HC,Hwang SY,Choi HY,Yoo HJ,Seo JA,Kim SG,Kim NH,Baik SH,Choi DS,Choi KM.Relationship between sarcopenia and nonalcoholic fatty liver disease:the Korean Sarcopenic Obesity Study.Hepatology 2014;59:1772-1778[PMID:23996808 DOI:10.1002/hep.26716]
25 Lee YH,Kim SU,Song K,Park JY,Kim DY,Ahn SH,Lee BW,Kang ES,Cha BS,Han KH.Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease:Nationwide surveys(KNHANES2008-2011).Hepatology 2016;63:776-786[PMID:26638128 DOI:10.1002/hep.28376]
26 Shida T,Akiyama K,Oh S,Sawai A,Isobe T,Okamoto Y,Ishige K,Mizokami Y,Yamagata K,Onizawa K,Tanaka H,Iijima H,Shoda J.Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.J Gastroenterol 2018;53:535-547[PMID:28791501 DOI:10.1007/s00535-017-1377-3]
27 Anand AC.Nutrition and Muscle in Cirrhosis.J Clin Exp Hepatol 2017;7:340-357[PMID:29234200 DOI:10.1016/j.jceh.2017.11.001]
28 Montano-Loza AJ,Angulo P,Meza-Junco J,Prado CM,Sawyer MB,Beaumont C,Esfandiari N,Ma M,Baracos VE.Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.J Cachexia Sarcopenia Muscle 2016;7:126-135[PMID:27493866 DOI:10.1002/jcsm.12039]
29 Hara N,Iwasa M,Sugimoto R,Mifuji-Moroka R,Yoshikawa K,Terasaka E,Hattori A,Ishidome M,Kobayashi Y,Hasegawa H,Iwata K,Takei Y.Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.Intern Med 2016;55:863-870[PMID:27086797 DOI:10.2169/internalmedicine.55.5676]
30 Carias S,Castellanos AL,Vilchez V,Nair R,Dela Cruz AC,Watkins J,Barrett T,Trushar P,Esser K,Gedaly R.Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.JGastroenterol Hepatol 2016;31:628-633[PMID:26399838 DOI:10.1111/jgh.13166]
31 Kaido T,Tamai Y,Hamaguchi Y,Okumura S,Kobayashi A,Shirai H,Yagi S,Kamo N,Hammad A,Inagaki N,Uemoto S.Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.Nutrition 2017;33:195-198[PMID:27649861 DOI:10.1016/j.nut.2016.07.002]
32 Hammad A,Kaido T,Hamaguchi Y,Okumura S,Kobayashi A,Shirai H,Kamo N,Yagi S,Uemoto S.Impact of sarcopenic overweight on the outcomes after living donor liver transplantation.Hepatobiliary Surg Nutr 2017;6:367-378[PMID:29312971 DOI:10.21037/hbsn.2017.02.02]
33 Spengler EK,O’Leary JG,Te HS,Rogal S,Pillai AA,Al-Osaimi A,Desai A,Fleming JN,Ganger D,Seetharam A,Tsoulfas G,Montenovo M,Lai JC.Liver Transplantation in the Obese Cirrhotic Patient.Transplantation 2017;101:2288-2296[PMID:28930104DOI:10.1097/TP.0000000000001794]
34 Richards J,Gunson B,Johnson J,Neuberger J.Weight gain and obesity after liver transplantation.Transpl Int 2005;18:461-466[PMID:15773968 DOI:10.1111/j.1432-2277.2004.00067.x]
35 Schütz T,Hudjetz H,Roske AE,Katzorke C,Kreymann G,Budde K,Fritsche L,Neumayer HH,Lochs H,Plauth M.Weight gain in long-term survivors of kidney or liver transplantation--another paradigm of sarcopenic obesity?Nutrition 2012;28:378-383[PMID:22304858 DOI:10.1016/j.nut.2011.07.019]
36 Choudhary NS,Saigal S,Saraf N,Mohanka R,Rastogi A,Goja S,Menon PB,Mishra S,Mittal A,Soin AS.Sarcopenic obesity with metabolic syndrome:a newly recognized entity following living donor liver transplantation.Clin Transplant 2015;29:211-215[PMID:25594826 DOI:10.1111/ctr.12505]
37 Johnson TM,Overgard EB,Cohen AE,Di Baise JK.Nutrition assessment and management in advanced liver disease.Nutr Clin Pract 2013;28:15-29[PMID:23319353 DOI:10.1177/0884533612469027]
38 Floreani A,Baragiotta A,Martines D,Naccarato R,D’odorico A.Plasma antioxidant levels in chronic cholestatic liver diseases.Aliment Pharmacol Ther 2000;14:353-358[PMID:10735930 DOI:10.1046/j.1365-2036.2000.00729.x]
39 Hansen KE,Johnson MG.An update on vitamin D for clinicians.Curr Opin Endocrinol Diabetes Obes 2016;23:440-444[PMID:27653000 DOI:10.1097/MED.0000000000000288]
40 Stokes CS,Volmer DA,Grünhage F,Lammert F.Vitamin D in chronic liver disease.Liver Int 2013;33:338-352[PMID:23402606DOI:10.1111/liv.12106]
41 Lim LY,Chalasani N.Vitamin d deficiency in patients with chronic liver disease and cirrhosis.Curr Gastroenterol Rep 2012;14:67-73[PMID:22113744 DOI:10.1007/s11894-011-0231-7]
42 Targher G,Byrne CD.Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases:is there a causal link?Endocrine2014;47:3-4[PMID:24595898 DOI:10.1007/s12020-014-0220-3]
43 Stokes CS,Krawczyk M,Reichel C,Lammert F,Grünhage F.Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis.Eur J Clin Invest 2014;44:176-183[PMID:24236541 DOI:10.1111/eci.12205]
44 Paternostro R,Wagner D,Reiberger T,Mandorfer M,Schwarzer R,Ferlitsch M,Trauner M,Peck-Radosavljevic M,Ferlitsch A.Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.Wien Klin Wochenschr 2017;129:8-15[PMID:27888359 DOI:10.1007/s00508-016-1127-1]
45 Putz-Bankuti C,Pilz S,Stojakovic T,Scharnagl H,Pieber TR,Trauner M,Obermayer-Pietsch B,Stauber RE.Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease.Liver Int 2012;32:845-851[PMID:22222013DOI:10.1111/j.1478-3231.2011.02735.x]
46 Arteh J,Narra S,Nair S.Prevalence of vitamin D deficiency in chronic liver disease.Dig Dis Sci 2010;55:2624-2628[PMID:19960254 DOI:10.1007/s10620-009-1069-9]
47 Fisher L,Fisher A.Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.Clin Gastroenterol Hepatol2007;5:513-520[PMID:17222588 DOI:10.1016/j.cgh.2006.10.015]
48 Jha AK,Jha SK,Kumar A,Dayal VM,Jha SK.Effect of replenishment of vitamin D on survival in patients with decompensated liver cirrhosis:A prospective study.World J Gastrointest Pathophysiol2017;8:133-141[PMID:28868183 DOI:10.4291/wjgp.v8.i3.133]
49 Kitson MT,Roberts SK.D-livering the message:the importance of vitamin D status in chronic liver disease.J Hepatol 2012;57:897-909[PMID:22634121 DOI:10.1016/j.jhep.2012.04.033]
50 Reese PP,Bloom RD,Feldman HI,Huverserian A,Thomasson A,Shults J,Hamano T,Goral S,Shaked A,Olthoff K,Rickels MR,Bleicher M,Leonard MB.Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation.Liver Int 2012;32:287-296[PMID:22098635 DOI:10.1111/j.1478-3231.2011.02638.x]
51 Skaaby T,Husemoen LL,Borglykke A,J?rgensen T,Thuesen BH,Pisinger C,Schmidt LE,Linneberg A.Vitamin D status,liver enzymes,and incident liver disease and mortality:a general population study.Endocrine 2014;47:213-220[PMID:24272594DOI:10.1007/s12020-013-0107-8]
52 Wang JB,Abnet CC,Chen W,Dawsey SM,Fan JH,Yin LY,Yin J,Major JM,Taylor PR,Qiao YL,Freedman ND.Association between serum 25(OH)vitamin D,incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials:a nested case-control study.Br J Cancer 2013;109:1997-2004[PMID:24008664 DOI:10.1038/bjc.2013.546]
53 Wortsman J,Matsuoka LY,Chen TC,Lu Z,Holick MF.Decreased bioavailability of vitamin D in obesity.Am J Clin Nutr 2000;72:690-693[PMID:10966885 DOI:10.1093/ajcn/72.3.690]
54 Stein EM,Strain G,Sinha N,Ortiz D,Pomp A,Dakin G,Mc Mahon DJ,Bockman R,Silverberg SJ.Vitamin D insufficiency prior to bariatric surgery:risk factors and a pilot treatment study.Clin Endocrinol(Oxf)2009;71:176-183[PMID:19018785 DOI:10.1111/j.1365-2265.2008.03470.x]
55 Chiu KC,Chu A,Go VL,Saad MF.Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.Am J Clin Nutr 2004;79:820-825[PMID:15113720 DOI:10.1093/ajcn/79.5.820]
56 Ganji V,Zhang X,Shaikh N,Tangpricha V.Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006.Am J Clin Nutr 2011;94:225-233[PMID:21613551 DOI:10.3945/ajcn.111.013516]
57 Barchetta I,De Bernardinis M,Capoccia D,Baroni MG,Fontana M,Fraioli A,Morini S,Leonetti F,Cavallo MG.Hypovitaminosis D is independently associated with metabolic syndrome in obese patients.PLo S One 2013;8:e68689[PMID:23935881 DOI:10.1371/journal.pone.0068689]
58 Shankar A,Sabanayagam C,Kalidindi S.Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes.Diabetes Care 2011;34:1114-1119[PMID:21430085 DOI:10.2337/dc10-1203]
59 Knekt P,Laaksonen M,Mattila C,H?rk?nen T,Marniemi J,Heli?vaara M,Rissanen H,Montonen J,Reunanen A.Serum vitamin D and subsequent occurrence of type 2 diabetes.Epidemiology 2008;19:666-671[PMID:18496468 DOI:10.1097/EDE.0b013e318176b8ad]
60 Kayaniyil S,Retnakaran R,Harris SB,Vieth R,Knight JA,Gerstein HC,Perkins BA,Zinman B,Hanley AJ.Prospective associations of vitamin D withβ-cell function and glycemia:the PROspective Metabolism and ISlet cell Evaluation(PROMISE)cohort study.Diabetes 2011;60:2947-2953[PMID:21911752 DOI:10.2337/db11-0465]
61 Grimnes G,Emaus N,Joakimsen RM,Figenschau Y,Jenssen T,Nj?lstad I,Schirmer H,Jorde R.Baseline serum 25-hydroxyvitamin D concentrations in the Troms?Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up.Diabet Med 2010;27:1107-1115[PMID:20854377 DOI:10.1111/j.1464-5491.2010.03092.x]
62 Lamendola CA,Ariel D,Feldman D,Reaven GM.Relations between obesity,insulin resistance,and 25-hydroxyvitamin D.Am J Clin Nutr 2012;95:1055-1059[PMID:22440850 DOI:10.3945/ajcn.111.032060]
63 Rajakumar K,de las Heras J,Lee S,Holick MF,Arslanian SA.25-hydroxyvitamin D concentrations and in vivo insulin sensitivity andβ-cell function relative to insulin sensitivity in black and white youth.Diabetes Care 2012;35:627-633[PMID:22238280 DOI:10.2337/dc11-1825]
64 Targher G,Bertolini L,Scala L,Cigolini M,Zenari L,Falezza G,Arcaro G.Associations between serum 25-hydroxyvitamin D3concentrations and liver histology in patients with non-alcoholic fatty liver disease.Nutr Metab Cardiovasc Dis 2007;17:517-524[PMID:16928437 DOI:10.1016/j.numecd.2006.04.002]
65 Dasarathy J,Periyalwar P,Allampati S,Bhinder V,Hawkins C,Brandt P,Khiyami A,McCullough AJ,Dasarathy S..Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease.Liver Int2014;34:e118-e127[PMID:24118743 DOI:10.1111/liv.12312]
66 Jablonski KL,Jovanovich A,Holmen J,Targher G,Mc Fann K,Kendrick J,Chonchol M.Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.Nutr Metab Cardiovasc Dis 2013;23:792-798[PMID:23415456 DOI:10.1016/j.numecd.2012.12.006]
67 Barchetta I,Angelico F,Del Ben M,Baroni MG,Pozzilli P,Morini S,Cavallo MG.Strong association between non alcoholic fatty liver disease(NAFLD)and low 25(OH)vitamin D levels in an adult population with normal serum liver enzymes.BMC Med 2011;9:85[PMID:21749681 DOI:10.1186/1741-7015-9-85]
68 Nelson JE,Roth CL,Wilson LA,Yates KP,Aouizerat B,MorganStevenson V,Whalen E,Hoofnagle A,Mason M,Gersuk V,Yeh MM,Kowdley KV.Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Nonalcoholic Fatty Liver Disease:Possible Role for MAPK and NF-κB?Am J Gastroenterol 2016;111:852-863[PMID:27002799 DOI:10.1038/ajg.2016.51]
69 Bril F,Maximos M,Portillo-Sanchez P,Biernacki D,Lomonaco R,Subbarayan S,Correa M,Lo M,Suman A,Cusi K.Relationship of vitamin D with insulin resistance and disease severity in nonalcoholic steatohepatitis.J Hepatol 2015;62:405-411[PMID:25195551 DOI:10.1016/j.jhep.2014.08.040]
70 European Association for the Study of the Liver.EASL Clinical Practice Guidelines:management of cholestatic liver diseases.J Hepatol 2009;51:237-267[PMID:19501929 DOI:10.1016/j.jhep.2009.04.009]
71 Leslie WD,Bernstein CN,Leboff MS;American Gastroenterological Association Clinical Practice Commitee.AGA technical review on osteoporosis in hepatic disorders.Gastroenterology 2003;125:941-966[PMID:12949738 DOI:10.1016/S0016-5085(03)01062-X]
72 Barchetta I,Cimini FA,Cavallo MG.Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease:Present and Future.Nutrients 2017;9:[PMID:28906453 DOI:10.3390/nu9091015]
73 Kitson MT,Pham A,Gordon A,Kemp W,Roberts SK.High-dose vitamin D supplementation and liver histology in NASH.Gut 2016;65:717-718[PMID:26294696 DOI:10.1136/gutjnl-2015-310417]
74 Barchetta I,Del Ben M,Angelico F,Di Martino M,Fraioli A,La Torre G,Saulle R,Perri L,Morini S,Tiberti C,Bertoccini L,Cimini FA,Panimolle F,Catalano C,Baroni MG,Cavallo MG.No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes:a randomized,double-blind,placebo-controlled trial.BMC Med 2016;14:92[PMID:27353492DOI:10.1186/s12916-016-0638-y]
75 Nagpal J,Pande JN,Bhartia A.A double-blind,randomized,placebo-controlled trial of the short-term effect of vitamin D3supplementation on insulin sensitivity in apparently healthy,middleaged,centrally obese men.Diabet Med 2009;26:19-27[PMID:19125756 DOI:10.1111/j.1464-5491.2008.02636.x]
76 von Hurst PR,Stonehouse W,Coad J.Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised,placebo-controlled trial.Br J Nutr 2010;103:549-555[PMID:19781131 DOI:10.1017/S0007114509992017]
77 Pittas AG,Dawson-Hughes B,Li T,Van Dam RM,Willett WC,Manson JE,Hu FB.Vitamin D and calcium intake in relation to type 2 diabetes in women.Diabetes Care 2006;29:650-656[PMID:16505521 DOI:10.2337/diacare.29.03.06.dc05-1961]
78 Stokes CS,Grünhage F,Baus C,Volmer DA,Wagenpfeil S,Riemenschneider M,Lammert F.Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease.Clin Nutr 2016;35:950-957[PMID:26212170 DOI:10.1016/j.clnu.2015.07.004]
79 Bitetto D,Fabris C,Falleti E,Fornasiere E,Fumolo E,Fontanini E,Cussigh A,Occhino G,Baccarani U,Pirisi M,Toniutto P.Vitamin D and the risk of acute allograft rejection following human liver transplantation.Liver Int 2010;30:417-444[PMID:19849776 DOI:10.1111/j.1478-3231.2009.02154.x]
80 Bjelakovic G,Nikolova D,Bjelakovic M,Gluud C.Vitamin Dsupplementation for chronic liver diseases in adults.Cochrane Database Syst Rev 2017;11:CD011564[PMID:29099543 DOI:10.1002/14651858.CD011564.pub2]
81 Collier JD,Ninkovic M,Compston JE.Guidelines on the management of osteoporosis associated with chronic liver disease.Gut 2002;50 Suppl 1:i1-i9[PMID:11788576 DOI:10.1136/gut.50.suppl_1.i1]
82 Dasarathy J,Varghese R,Feldman A,Khiyami A,Mc Cullough AJ,Dasarathy S.Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.J Nutr 2017;147:1938-1946[PMID:28814531 DOI:10.3945/jn.117.254292]
83 Parola M,Leonarduzzi G,Biasi F,Albano E,Biocca ME,Poli G,Dianzani MU.Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis.Hepatology 1992;16:1014-1021[PMID:1398481 DOI:10.1002/hep.1840160426]
84 Houglum K,Venkataramani A,Lyche K,Chojkier M.A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.Gastroenterology 1997;113:1069-1073[PMID:9322499 DOI:10.1053/gast.1997.v113.pm9322499]
85 Sanyal AJ,Chalasani N,Kowdley KV,Mc Cullough A,Diehl AM,Bass NM,Neuschwander-Tetri BA,Lavine JE,Tonascia J,Unalp A,Van Natta M,Clark J,Brunt EM,Kleiner DE,Hoofnagle JH,Robuck PR;NASH CRN.Pioglitazone,vitamin E,or placebo for nonalcoholic steatohepatitis.N Engl J Med 2010;362:1675-1685[PMID:20427778 DOI:10.1056/NEJMoa0907929]
86 Chalasani N,Younossi Z,Lavine JE,Charlton M,Cusi K,Rinella M,Harrison SA,Brunt EM,Sanyal AJ.The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the Study of Liver Diseases.Hepatology2018;67:328-357[PMID:28714183 DOI:10.1002/hep.29367]
87 Mu?oz SJ,Heubi JE,Balistreri WF,Maddrey WC.Vitamin E deficiency in primary biliary cirrhosis:gastrointestinal malabsorption,frequency and relationship to other lipid-soluble vitamins.Hepatology 1989;9:525-531[PMID:2925155 DOI:10.1002/hep.1840090403]
88 Jeffrey GP,Muller DP,Burroughs AK,Matthews S,Kemp C,Epstein O,Metcalfe TA,Southam E,Tazir-Melboucy M,Thomas PK.Vitamin E deficiency and its clinical significance in adults with primary biliary cirrhosis and other forms of chronic liver disease.J Hepatol 1987;4:307-317[PMID:3036938 DOI:10.1016/S0168-8278(87)80539-1]
89 Leo MA,Rosman AS,Lieber CS.Differential depletion of carotenoids and tocopherol in liver disease.Hepatology 1993;17:977-986[PMID:8514270 DOI:10.1002/hep.1840170606]
90 Grüngreiff K,Reinhold D,Wedemeyer H.The role of zinc in liver cirrhosis.Ann Hepatol 2016;15:7-16[PMID:26626635 DOI:10.5604/16652681.1184191]
91 Ma J,Betts NM.Zinc and copper intakes and their major food sources for older adults in the 1994-96 continuing survey of food intakes by individuals(CSFII).J Nutr 2000;130:2838-2843[PMID:11053529 DOI:10.1093/jn/130.11.2838]
92 Huskisson E,Maggini S,Ruf M.The role of vitamins and minerals in energy metabolism and well-being.J Int Med Res 2007;35:277-289[PMID:17593855 DOI:10.1177/147323000703500301]
93 Gibson RS,King JC,Lowe N.A Review of Dietary Zinc Recommendations.Food Nutr Bull 2016;37:443-460[PMID:27312357 DOI:10.1177/0379572116652252]
94 Himoto T,Masaki T.Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.Nutrients 2018;10:[PMID:29342898 DOI:10.3390/nu10010088]
95 Chiba M,Katayama K,Takeda R,Morita R,Iwahashi K,Onishi Y,Kita H,Nishio A,Kanno T,Saito T,Maeda K,Naito M,Michida T,Ito T.Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine.Hepatol Res 2013;43:365-373[PMID:22994500 DOI:10.1111/j.1872-034X.2012.01093.x]
96 Nusrat S,Khan MS,Fazili J,Madhoun MF.Cirrhosis and its complications:evidence based treatment.World J Gastroenterol2014;20:5442-5460[PMID:24833875 DOI:10.3748/wjg.v20.i18.5442]
97 Van der Rijt CC,Schalm SW,Schat H,Foeken K,De Jong G.Overt hepatic encephalopathy precipitated by zinc deficiency.Gastroenterology 1991;100:1114-1118[PMID:2001810 DOI:10.1016/0016-5085(91)90290-2]
98 Rabbani P,Prasad AS.Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats.Am J Physiol 1978; 235:E203-E206 [PMID: 686166 DOI: 10.1152/ajpendo.1978.235.2.E203]
99 Katayama K,Saito M,Kawaguchi T,Endo R,Sawara K,Nishiguchi S,Kato A,Kohgo H,Suzuki K,Sakaida I,Ueno Y,Habu D,Ito T,Moriwaki H,Suzuki K.Effect of zinc on liver cirrhosis with hyperammonemia:a preliminary randomized,placebo-controlled double-blind trial.Nutrition 2014;30:1409-1414[PMID:25280421DOI:10.1016/j.nut.2014.04.018]
100 Marchesini G,Fabbri A,Bianchi G,Brizi M,Zoli M.Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.Hepatology 1996;23:1084-1092[PMID:8621138 DOI:10.1053/jhep.1996.v23.pm0008621138]
101 Takuma Y,Nouso K,Makino Y,Hayashi M,Takahashi H.Clinical trial:oral zinc in hepatic encephalopathy.Aliment Pharmacol Ther 2010;32:1080-1090[PMID:20822500 DOI:10.1111/j.1365-2036.2010.04448.x]
102 Mousa N,Abdel-Razik A,Zaher A,Hamed M,Shiha G,Effat N,Elbaz S,Elhelaly R,Hafez M,El-Wakeel N,Eldars W.The role of antioxidants and zinc in minimal hepatic encephalopathy:a randomized trial.Therap Adv Gastroenterol 2016;9:684-691[PMID:27582881 DOI:10.1177/1756283X16645049]
103 Mohammad MK,Zhou Z,Cave M,Barve A,Mc Clain CJ.Zinc and liver disease.Nutr Clin Pract 2012;27:8-20[PMID:22307488DOI:10.1177/0884533611433534]
104 Tabibian JH,Gerstenblith MR,Tedford RJ,Junkins-Hopkins JM,Abuav R.Necrolytic acral erythema as a cutaneous marker of hepatitis C:report of two cases and review.Dig Dis Sci 2010;55:2735-2743[PMID:20499177 DOI:10.1007/s10620-010-1273-7]
105 Pimentel CF,Lai M.Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease.Med Clin North Am 2016;100:1303-1327[PMID:27745596 DOI:10.1016/j.mcna.2016.06.010]
106 Tandon P,Raman M,Mourtzakis M,Merli M.A practical approach to nutritional screening and assessment in cirrhosis.Hepatology2017;65:1044-1057[PMID:28027577 DOI:10.1002/hep.29003]
107 Romani AM.Magnesium homeostasis and alcohol consumption.Magnes Res 2008;21:197-204[PMID:19271417]
108 Cohen L.Magnesium and liver cirrhosis:a hypothesis.Magnesium1985;4:1-4[PMID:4033201]
109 Raheli?D,Kujundzi?M,Romi?Z,Brki?K,Petrovecki M.Serum concentration of zinc,copper,manganese and magnesium in patients with liver cirrhosis.Coll Antropol 2006;30:523-528[PMID:17058518]
110 Agarwal A,Avarebeel S,Choudhary NS,Goudar M,Tejaswini CJ.Correlation of Trace Elements in Patients of Chronic Liver Disease with Respect to Child-Turcotte-Pugh Scoring System.J Clin Diagn Res 2017;11:OC25-OC28[PMID:29207755 DOI:10.7860/JCDR/2017/26519.10655]
111 Kar K,Dasgupta A,Vijaya Bhaskar M,Sudhakar K.Alteration of micronutrient status in compensated and decompensated liver cirrhosis.Indian J Clin Biochem 2014;29:232-237[PMID:24757308 DOI:10.1007/s12291-013-0349-5]
112 Nangliya V,Sharma A,Yadav D,Sunder S,Nijhawan S,Mishra S.Study of trace elements in liver cirrhosis patients and their role in prognosis of disease.Biol Trace Elem Res 2015;165:35-40[PMID:25613584 DOI:10.1007/s12011-015-0237-3]
113 Koivisto M,Valta P,H?ckerstedt K,Lindgren L.Magnesium depletion in chronic terminal liver cirrhosis.Clin Transplant 2002;16:325-328[PMID:12225427 DOI:10.1034/j.1399-0012.2002.01141.x]
114 Chao A,Waitzberg D,de Jesus RP,Bueno AA,Kha V,Allen K,Kappus M,Medici V.Malnutrition and Nutritional Support in Alcoholic Liver Disease:a Review.Curr Gastroenterol Rep 2016;18:65[PMID:27787787 DOI:10.1007/s11894-016-0539-4]
115 O'Shea RS,Dasarathy S,Mc Cullough AJ;Practice Guideline Committee of the American Association for the Study of Liver Diseases;Practice Parameters Committee of the American College of Gastroenterology.Alcoholic liver disease.Hepatology 2010;51:307-328[PMID:20034030 DOI:10.1002/hep.23258]
116 Rossi RE,Conte D,Massironi S.Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease:Overview of available evidence and open issues.Dig Liver Dis 2015;47:819-825[PMID:26164399 DOI:10.1016/j.dld.2015.05.021]
117 Amodio P,Bemeur C,Butterworth R,Cordoba J,Kato A,Montagnese S,Uribe M,Vilstrup H,Morgan MY.The nutritional management of hepatic encephalopathy in patients with cirrhosis:International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus.Hepatology 2013;58:325-336[PMID:23471642 DOI:10.1002/hep.26370]
118 Merli M,Giusto M,Lucidi C,Giannelli V,Pentassuglio I,Di Gregorio V,Lattanzi B,Riggio O.Muscle depletion increases the risk of overt and minimal hepatic encephalopathy:results of a prospective study.Metab Brain Dis 2013;28:281-284[PMID:23224378 DOI:10.1007/s11011-012-9365-z]
119 Plauth M,Merli M,Kondrup J,Weimann A,Ferenci P,Müller MJ;ESPEN Consensus Group.ESPEN guidelines for nutrition in liver disease and transplantation.Clin Nutr 1997;16:43-55[PMID:16844569 DOI:10.1016/S0261-5614(97)80022-2]
120 Plauth M,CabréE,Riggio O,Assis-Camilo M,Pirlich M,Kondrup J;DGEM(German Society for Nutritional Medicine),Ferenci P,Holm E,Vom Dahl S,Müller MJ,Nolte W;ESPEN(European Society for Parenteral and Enteral Nutrition).ESPEN Guidelines on Enteral Nutrition:Liver disease.Clin Nutr 2006;25:285-294[PMID:16707194 DOI:10.1016/j.clnu.2006.01.018]
121 Córdoba J,López-Hellín J,Planas M,Sabín P,Sanpedro F,Castro F,Esteban R,Guardia J.Normal protein diet for episodic hepatic encephalopathy:results of a randomized study.J Hepatol 2004;41:38-43[PMID:15246205 DOI:10.1016/j.jhep.2004.03.023]
122 BESSMAN AN,MIRICK GS.Blood ammonia levels following the ingestion of casein and whole blood.J Clin Invest 1958;37:990-998[PMID:13563627 DOI:10.1172/JCI103695]
123 Fenton JC,Knight EJ,Humpherson PL.Milk-and-cheese diet in portal-systemic encephalopathy.Lancet 1966;1:164-166[PMID:4159095 DOI:10.1016/S0140-6736(66)90696-9]
124 Greenberger NJ,Carley J,Schenker S,Bettinger I,Stamnes C,Beyer P.Effect of vegetable and animal protein diets in chronic hepatic encephalopathy.Am J Dig Dis 1977;22:845-855[PMID:335882 DOI:10.1007/BF01076158]
125 Gheorghe L,Iacob R,V?dan R,Iacob S,Gheorghe C.Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.Rom J Gastroenterol 2005;14:231-238[PMID:16200232]
126 Uribe M,Dibildox M,Malpica S,Guillermo E,Villallobos A,Nieto L,Vargas F,Garcia Ramos G.Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus.Gastroenterology 1985;88:901-907[PMID:2982694 DOI:10.1016/S0016-5085(85)80006-8]
127 Weber FL Jr,Minco D,Fresard KM,Banwell JG.Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects.Gastroenterology 1985;89:538-544[PMID:2991068 DOI:10.1016/0016-5085(85)90448-2]
128 Uribe M,Márquez MA,Garcia Ramos G,Ramos-Uribe MH,Vargas F,Villalobos A,Ramos C.Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets.Acontrolled crossover study.Dig Dis Sci 1982;27:1109-1116[PMID:6756833 DOI:10.1007/BF01391449]
129 Shekib LA,Zoueil ME,Youssef MM,Mohamed SW.Amino acid composition and In Vitro digestibility of lentil and rice proteins and their mixture(Koshary).Food Chem 1986;20:61-67[DOI:10.1016/0308-8146(86)90167-6]
130 Silk DB.Branched chain amino acids in liver disease:fact or fantasy?Gut 1986;27 Suppl 1:103-110[PMID:3098636 DOI:10.1136/gut.27.Suppl_1.103]
131 Fischer JE,Baldessarini RJ.False neurotransmitters and hepatic failure.Lancet 1971;2:75-80[PMID:4103986 DOI:10.1016/S0140-6736(71)92048-4]
132 Dam G,Ott P,Aagaard NK,Vilstrup H.Branched-chain amino acids and muscle ammonia detoxification in cirrhosis.Metab Brain Dis 2013;28:217-220[PMID:23315357 DOI:10.1007/s11011-013-9377-3]
133 Gluud LL,Dam G,Les I,Marchesini G,Borre M,Aagaard NK,Vilstrup H.Branched-chain amino acids for people with hepatic encephalopathy.Cochrane Database Syst Rev 2017;5:CD001939[PMID:28518283 DOI:10.1002/14651858.CD001939.pub4]
134 NCD Risk Factor Collaboration(NCD-Ris C).Trends in adult body-mass index in 200 countries from 1975 to 2014:a pooled analysis of 1698 population-based measurement studies with 19·2million participants.Lancet 2016;387:1377-1396[PMID:27115820DOI:10.1016/S0140-6736(16)30054-X]
135 Angrisani L,Santonicola A,Iovino P,Formisano G,Buchwald H,Scopinaro N.Bariatric Surgery Worldwide 2013.Obes Surg2015;25:1822-1832[PMID:25835983 DOI:10.1007/s11695-015-1657-z]
136 Diehl AM,Day C.Cause,Pathogenesis,and Treatment of Nonalcoholic Steatohepatitis.N Engl J Med 2017;377:2063-2072[PMID:29166236 DOI:10.1056/NEJMra1503519]
137 Angulo P,Kleiner DE,Dam-Larsen S,Adams LA,Bjornsson ES,Charatcharoenwitthaya P,Mills PR,Keach JC,Lafferty HD,Stahler A,Haflidadottir S,Bendtsen F.Liver Fibrosis,but No Other Histologic Features,Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.Gastroenterology 2015;149:389-97.e10[PMID:25935633 DOI:10.1053/j.gastro.2015.04.043]
138 Ekstedt M,Hagstr?m H,Nasr P,Fredrikson M,St?l P,Kechagias S,Hultcrantz R.Fibrosis stage is the strongest predictor for diseasespecific mortality in NAFLD after up to 33 years of follow-up.Hepatology 2015;61:1547-1554[PMID:25125077 DOI:10.1002/hep.27368]
139 Bhaskaran K,Douglas I,Forbes H,dos-Santos-Silva I,Leon DA,Smeeth L.Body-mass index and risk of 22 specific cancers:a population-based cohort study of 5·24 million UK adults.Lancet 2014;384:755-765[PMID:25129328 DOI:10.1016/S0140-6736(14)60892-8]
140 Watt KD.Reducing the load:the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation.Liver Transpl 2012;18 Suppl 2:S52-S58[PMID:22821716 DOI:10.1002/lt.23515]
141 Iannelli A.Bariatric surgery and liver transplant.Liver Transpl2017;23:1369-1370[PMID:28945954 DOI:10.1002/lt.24948]
142 Saab S,Lalezari D,Pruthi P,Alper T,Tong MJ.The impact of obesity on patient survival in liver transplant recipients:a meta-analysis.Liver Int 2015;35:164-170[PMID:24313970 DOI:10.1111/liv.12431]
143 Perez-Protto SE,Quintini C,Reynolds LF,You J,Cywinski JB,Sessler DI,Miller C.Comparable graft and patient survival in lean and obese liver transplant recipients.Liver Transpl 2013;19:907-915[PMID:23744721 DOI:10.1002/lt.23680]
144 Karagozian R,Bhardwaj G,Wakefield DB,Baffy G.Obesity paradox in advanced liver disease:obesity is associated with lower mortality in hospitalized patients with cirrhosis.Liver Int 2016;36:1450-1456[PMID:27037497 DOI:10.1111/liv.13137]
145 Terjimanian MN,Harbaugh CM,Hussain A,Olugbade KO Jr,Waits SA,Wang SC,Sonnenday CJ,Englesbe MJ.Abdominal adiposity,body composition and survival after liver transplantation.Clin Transplant 2016;30:289-294[PMID:26717257 DOI:10.1111/ctr.12688]
146 Hamaguchi Y,Kaido T,Okumura S,Kobayashi A,Shirai H,Yagi S,Kamo N,Okajima H,Uemoto S.Impact of Skeletal Muscle Mass Index,Intramuscular Adipose Tissue Content,and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.Transplantation 2017;101:565-574[PMID:27926595 DOI:10.1097/TP.0000000000001587]
147 Lazzati A,Iannelli A,Schneck AS,Nelson AC,Katsahian S,Gugenheim J,Azoulay D.Bariatric surgery and liver transplantation:a systematic review a new frontier for bariatric surgery.Obes Surg 2015;25:134-142[PMID:25337867 DOI:10.1007/s11695-014-1430-8]
148 Mosko JD,Nguyen GC.Increased perioperative mortality following bariatric surgery among patients with cirrhosis.Clin Gastroenterol Hepatol 2011;9:897-901[PMID:21782772 DOI:10.1016/j.cgh.2011.07.007]
149 Duvoux C,Roudot-Thoraval F,Decaens T,Pessione F,Badran H,Piardi T,Francoz C,Compagnon P,Vanlemmens C,Dumortier J,Dharancy S,Gugenheim J,Bernard PH,Adam R,Radenne S,Muscari F,Conti F,Hardwigsen J,Pageaux GP,Chazouillères O,Salame E,Hilleret MN,Lebray P,Abergel A,Debette-Gratien M,Kluger MD,Mallat A,Azoulay D,Cherqui D;Liver Transplantation French Study Group.Liver transplantation for hepatocellular carcinoma:a model includingα-fetoprotein improves the performance of Milan criteria.Gastroenterology 2012;143:986-94.e3;quiz e14-5[PMID:22750200DOI:10.1053/j.gastro.2012.05.052]
150 Mazzaferro V,Sposito C,Zhou J,Pinna AD,De Carlis L,Fan J,Cescon M,Di Sandro S,Yi-Feng H,Lauterio A,Bongini M,Cucchetti A.Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.Gastroenterology 2018;154:128-139[PMID:28989060 DOI:10.1053/j.gastro.2017.09.025]
151 Al-Nowaylati AR,Al-Haddad BJ,Dorman RB,Alsaied OA,Lake JR,Chinnakotla S,Slusarek BM,Sampson BK,Ikramuddin S,Buchwald H,Leslie DB.Gastric bypass after liver transplantation.Liver Transpl2013;19:1324-1329[PMID:24039124 DOI:10.1002/lt.23734]
152 Heimbach JK,Watt KD,Poterucha JJ,Ziller NF,Cecco SD,Charlton MR,Hay JE,Wiesner RH,Sanchez W,Rosen CB,Swain JM.Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.Am J Transplant 2013;13:363-368[PMID:23137119 DOI:10.1111/j.1600-6143.2012.04318.x]
153 Prakash G,Drenick EJ,Wexler H,De Lucia L,Finegold SM.Microbial flora in the bypassed jejunum of patients with biliopancreatic bypass for obesity.Am J Clin Nutr 1987;46:273-276[PMID:3618530 DOI:10.1093/ajcn/46.2.273]
154 D'Albuquerque LA,Gonzalez AM,Wahle RC,de Oliveira Souza E,Mancero JM,de Oliveira e Silva A.Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery.Liver Transpl 2008;14:881-885[PMID:18508357DOI:10.1002/lt.21472]
155 Rogers CC,Alloway RR,Alexander JW,Cardi M,Trofe J,Vinks AA.Pharmacokinetics of mycophenolic acid,tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients:a pilot study.Clin Transplant 2008;22:281-291[PMID:18482049 DOI:10.1111/j.1399-0012.2007.00783.x]
156 Clapp B,Wynn M,Martyn C,Foster C,O’Dell M,Tyroch A.Long term(7 or more years)outcomes of the sleeve gastrectomy:a metaanalysis.Surg Obes Relat Dis 2018;14:741-747[PMID:29625744DOI:10.1016/j.soard.2018.02.027]
157 Noel P,Nedelcu M,Eddbali I,Manos T,Gagner M.What are the long-term results 8 years after sleeve gastrectomy?Surg Obes Relat Dis 2017;13:1110-1115[PMID:28755888 DOI:10.1016/j.soard.2017.03.007]
158 Berger ER,Clements RH,Morton JM,Huffman KM,Wolfe BM,Nguyen NT,Ko CY,Hutter MM.The Impact of Different Surgical Techniques on Outcomes in Laparoscopic Sleeve Gastrectomies:The First Report from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program(MBSAQIP).Ann Surg 2016;264:464-473[PMID:27433904 DOI:10.1097/SLA.0000000000001851]
159 Peterli R,W?lnerhanssen BK,Vetter D,Nett P,Gass M,Borbély Y,Peters T,Schiesser M,Schultes B,Beglinger C,Drewe J,Bueter M.Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study(SM-BOSS).Ann Surg 2017;265:466-473[PMID:28170356 DOI:10.1097/SLA.0000000000001929]
160 Schneck AS,Anty R,Patouraux S,Bonnafous S,Rousseau D,Lebeaupin C,Bailly-Maitre B,Sans A,Tran A,Gugenheim J,Iannelli A,Gual P.Roux-En Y Gastric Bypass Results in LongTerm Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis.Front Physiol 2016;7:344[PMID:27594839 DOI:10.3389/fphys.2016.00344]
161 Geerts A,Darius T,Chapelle T,Roeyen G,Francque S,Libbrecht L,Nevens F,Pirenne J,Troisi R.The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery.Transplant Proc 2010;42:4395-4398[PMID:21168706 DOI:10.1016/j.transproceed.2010.07.010]
162 Sj?str?m L.Review of the key results from the Swedish Obese Subjects(SOS)trial-a prospective controlled intervention study of bariatric surgery.J Intern Med 2013;273:219-234[PMID:23163728 DOI:10.1111/joim.12012]
163 Adams TD,Davidson LE,Litwin SE,Kim J,Kolotkin RL,Nanjee MN,Gutierrez JM,Frogley SJ,Ibele AR,Brinton EA,Hopkins PN,Mc Kinlay R,Simper SC,Hunt SC.Weight and Metabolic Outcomes 12 Years after Gastric Bypass.N Engl J Med 2017;377:1143-1155[PMID:28930514 DOI:10.1056/NEJMoa1700459]
164 Safwan M,Collins KM,Abouljoud MS,Salgia R.Outcome of liver transplantation in patients with prior bariatric surgery.Liver Transpl2017;23:1415-1421[PMID:28752920 DOI:10.1002/lt.24832]
165 Shaheen O,Siejka J,Thatigotla B,Pham DT.A systematic review of portomesenteric vein thrombosis after sleeve gastrectomy.Surg Obes Relat Dis 2017;13:1422-1431[PMID:28526434 DOI:10.1016/j.soard.2017.03.015]
2 Welzel TM,Graubard BI,Zeuzem S,El-Serag HB,Davila JA,Mc Glynn KA.Metabolic syndrome increases the risk of primary liver cancer in the United States:a study in the SEER-Medicare database.Hepatology 2011;54:463-471[PMID:21538440 DOI:10.1002/hep.24397]
3 Starley BQ,Calcagno CJ,Harrison SA.Nonalcoholic fatty liver disease and hepatocellular carcinoma:a weighty connection.Hepatology 2010;51:1820-1832[PMID:20432259 DOI:10.1002/hep.23594]
4 Ascha MS,Hanouneh IA,Lopez R,Tamimi TA,Feldstein AF,Zein NN.The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.Hepatology 2010;51:1972-1978[PMID:20209604 DOI:10.1002/hep.23527]
5 Chalasani N,Younossi Z,Lavine JE,Diehl AM,Brunt EM,Cusi K,Charlton M,Sanyal AJ.The diagnosis and management of nonalcoholic fatty liver disease:practice Guideline by the American Association for the Study of Liver Diseases,American College of Gastroenterology,and the American Gastroenterological Association.Hepatology 2012;55:2005-2023[PMID:22488764 DOI:10.1002/hep.25762]
6 Angulo P.Long-term mortality in nonalcoholic fatty liver disease:is liver histology of any prognostic significance?Hepatology 2010;51:373-375[PMID:20101746 DOI:10.1002/hep.23521]
7 Raynard B,Balian A,Fallik D,Capron F,Bedossa P,Chaput JC,Naveau S.Risk factors of fibrosis in alcohol-induced liver disease.Hepatology 2002;35:635-638[PMID:11870378 DOI:10.1053/jhep.2002.31782]
8 Ortiz V,Berenguer M,Rayón JM,Carrasco D,Berenguer J.Contribution of obesity to hepatitis C-related fibrosis progression.Am J Gastroenterol 2002;97:2408-2414[PMID:12358265 DOI:10.1111/j.1572-0241.2002.05995.x]
9 Bellentani S,Saccoccio G,Masutti F,CrocèLS,Brandi G,Sasso F,Cristanini G,Tiribelli C.Prevalence of and risk factors for hepatic steatosis in Northern Italy.Ann Intern Med 2000;132:112-117[PMID:10644271 DOI:10.7326/0003-4819-132-2-200001180-00029]
10 Ekstedt M,Franzén LE,Holmqvist M,Bendtsen P,Mathiesen UL,Bodemar G,Kechagias S.Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.Scand J Gastroenterol 2009;44:366-374[PMID:19016382 DOI:10.1080/00365520802555991]
11 Liu B,Balkwill A,Reeves G,Beral V;Million Women Study Collaborators.Body mass index and risk of liver cirrhosis in middle aged UK women:prospective study.BMJ 2010;340:c912[PMID:20223875 DOI:10.1136/bmj.c912]
12 Everhart JE,Lok AS,Kim HY,Morgan TR,Lindsay KL,Chung RT,Bonkovsky HL,Ghany MG;HALT-C Trial Group.Weightrelated effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.Gastroenterology 2009;137:549-557[PMID:19445938 DOI:10.1053/j.gastro.2009.05.007]
13 Berzigotti A,Abraldes JG.Impact of obesity and insulin-resistance on cirrhosis and portal hypertension.Gastroenterol Hepatol 2013;36:527-533[PMID:23731977 DOI:10.1016/j.gastrohep.2013.03.005]
14 Berzigotti A,Albillos A,Villanueva C,GenescáJ,Ardevol A,Augustín S,Calleja JL,Ba?ares R,García-Pagán JC,Mesonero F,Bosch J;Ciberehd Sport Diet Collaborative Group.Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity:The Sport Diet study.Hepatology2017;65:1293-1305[PMID:27997989 DOI:10.1002/hep.28992]
15 Ayala R,Grande S,Bustelos R,Ribera C,García-Sesma A,Jimenez C,Moreno E,Martínez-López J.Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients.BMC Gastroenterol 2012;12:114[PMID:22909075 DOI:10.1186/1471-230X-12-114]
16 Allman-Farinelli MA.Obesity and venous thrombosis:a review.Semin Thromb Hemost 2011;37:903-907[PMID:22198855 DOI:10.1055/s-0031-1297369]
17 La Mattina JC,Foley DP,Fernandez LA,Pirsch JD,Musat AI,D’Alessandro AM,Mezrich JD.Complications associated with liver transplantation in the obese recipient.Clin Transplant 2012;26:910-918[PMID:22694047 DOI:10.1111/j.1399-0012.2012.01669.x]
18 Cruz-Jentoft AJ,Baeyens JP,Bauer JM,Boirie Y,Cederholm T,Landi F,Martin FC,Michel JP,Rolland Y,Schneider SM,TopinkováE,Vandewoude M,Zamboni M;European Working Group on Sarcopenia in Older People.Sarcopenia:European consensus on definition and diagnosis:Report of the European Working Group on Sarcopenia in Older People.Age Ageing 2010;39:412-423[PMID:20392703 DOI:10.1093/ageing/afq034]
19 Rolland Y,Lauwers-Cances V,Cristini C,Abellan van Kan G,Janssen I,Morley JE,Vellas B.Difficulties with physical function associated with obesity,sarcopenia,and sarcopenic-obesity in community-dwelling elderly women:the EPIDOS(EPIDemiologie de l’OSteoporose)Study.Am J Clin Nutr 2009;89:1895-1900[PMID:19369381 DOI:10.3945/ajcn.2008.26950]
20 Koster A,Ding J,Stenholm S,Caserotti P,Houston DK,Nicklas BJ,You T,Lee JS,Visser M,Newman AB,Schwartz AV,Cauley JA,Tylavsky FA,Goodpaster BH,Kritchevsky SB,Harris TB;Health ABC study.Does the amount of fat mass predict age-related loss of lean mass,muscle strength,and muscle quality in older adults?JGerontol A Biol Sci Med Sci 2011;66:888-895[PMID:21572082DOI:10.1093/gerona/glr070]
21 Beavers KM,Hsu FC,Houston DK,Beavers DP,Harris TB,Hue TF,Kim LJ,Koster A,Penninx BW,Simonsick EM,Strotmeyer ES,Kritchevsky SB,Nicklas BJ;Health ABC Study.The role of metabolic syndrome,adiposity,and inflammation in physical performance in the Health ABC Study.J Gerontol A Biol Sci Med Sci2013;68:617-623[PMID:23109678 DOI:10.1093/gerona/gls213]
22 European Association for the Study of the Liver(EASL),European Association for the Study of Diabetes(EASD),European Association for the Study of Obesity(EASO).EASL-EASD-EASOClinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease.Obes Facts 2016;9:65-90[PMID:27055256DOI:10.1159/000443344]
23 Tovo CV,Fernandes SA,Buss C,de Mattos AA.Sarcopenia and non-alcoholic fatty liver disease:Is there a relationship?A systematic review.World J Hepatol 2017;9:326-332[PMID:28293382 DOI:10.4254/wjh.v9.i6.326]
24 Hong HC,Hwang SY,Choi HY,Yoo HJ,Seo JA,Kim SG,Kim NH,Baik SH,Choi DS,Choi KM.Relationship between sarcopenia and nonalcoholic fatty liver disease:the Korean Sarcopenic Obesity Study.Hepatology 2014;59:1772-1778[PMID:23996808 DOI:10.1002/hep.26716]
25 Lee YH,Kim SU,Song K,Park JY,Kim DY,Ahn SH,Lee BW,Kang ES,Cha BS,Han KH.Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease:Nationwide surveys(KNHANES2008-2011).Hepatology 2016;63:776-786[PMID:26638128 DOI:10.1002/hep.28376]
26 Shida T,Akiyama K,Oh S,Sawai A,Isobe T,Okamoto Y,Ishige K,Mizokami Y,Yamagata K,Onizawa K,Tanaka H,Iijima H,Shoda J.Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease.J Gastroenterol 2018;53:535-547[PMID:28791501 DOI:10.1007/s00535-017-1377-3]
27 Anand AC.Nutrition and Muscle in Cirrhosis.J Clin Exp Hepatol 2017;7:340-357[PMID:29234200 DOI:10.1016/j.jceh.2017.11.001]
28 Montano-Loza AJ,Angulo P,Meza-Junco J,Prado CM,Sawyer MB,Beaumont C,Esfandiari N,Ma M,Baracos VE.Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.J Cachexia Sarcopenia Muscle 2016;7:126-135[PMID:27493866 DOI:10.1002/jcsm.12039]
29 Hara N,Iwasa M,Sugimoto R,Mifuji-Moroka R,Yoshikawa K,Terasaka E,Hattori A,Ishidome M,Kobayashi Y,Hasegawa H,Iwata K,Takei Y.Sarcopenia and Sarcopenic Obesity Are Prognostic Factors for Overall Survival in Patients with Cirrhosis.Intern Med 2016;55:863-870[PMID:27086797 DOI:10.2169/internalmedicine.55.5676]
30 Carias S,Castellanos AL,Vilchez V,Nair R,Dela Cruz AC,Watkins J,Barrett T,Trushar P,Esser K,Gedaly R.Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.JGastroenterol Hepatol 2016;31:628-633[PMID:26399838 DOI:10.1111/jgh.13166]
31 Kaido T,Tamai Y,Hamaguchi Y,Okumura S,Kobayashi A,Shirai H,Yagi S,Kamo N,Hammad A,Inagaki N,Uemoto S.Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.Nutrition 2017;33:195-198[PMID:27649861 DOI:10.1016/j.nut.2016.07.002]
32 Hammad A,Kaido T,Hamaguchi Y,Okumura S,Kobayashi A,Shirai H,Kamo N,Yagi S,Uemoto S.Impact of sarcopenic overweight on the outcomes after living donor liver transplantation.Hepatobiliary Surg Nutr 2017;6:367-378[PMID:29312971 DOI:10.21037/hbsn.2017.02.02]
33 Spengler EK,O’Leary JG,Te HS,Rogal S,Pillai AA,Al-Osaimi A,Desai A,Fleming JN,Ganger D,Seetharam A,Tsoulfas G,Montenovo M,Lai JC.Liver Transplantation in the Obese Cirrhotic Patient.Transplantation 2017;101:2288-2296[PMID:28930104DOI:10.1097/TP.0000000000001794]
34 Richards J,Gunson B,Johnson J,Neuberger J.Weight gain and obesity after liver transplantation.Transpl Int 2005;18:461-466[PMID:15773968 DOI:10.1111/j.1432-2277.2004.00067.x]
35 Schütz T,Hudjetz H,Roske AE,Katzorke C,Kreymann G,Budde K,Fritsche L,Neumayer HH,Lochs H,Plauth M.Weight gain in long-term survivors of kidney or liver transplantation--another paradigm of sarcopenic obesity?Nutrition 2012;28:378-383[PMID:22304858 DOI:10.1016/j.nut.2011.07.019]
36 Choudhary NS,Saigal S,Saraf N,Mohanka R,Rastogi A,Goja S,Menon PB,Mishra S,Mittal A,Soin AS.Sarcopenic obesity with metabolic syndrome:a newly recognized entity following living donor liver transplantation.Clin Transplant 2015;29:211-215[PMID:25594826 DOI:10.1111/ctr.12505]
37 Johnson TM,Overgard EB,Cohen AE,Di Baise JK.Nutrition assessment and management in advanced liver disease.Nutr Clin Pract 2013;28:15-29[PMID:23319353 DOI:10.1177/0884533612469027]
38 Floreani A,Baragiotta A,Martines D,Naccarato R,D’odorico A.Plasma antioxidant levels in chronic cholestatic liver diseases.Aliment Pharmacol Ther 2000;14:353-358[PMID:10735930 DOI:10.1046/j.1365-2036.2000.00729.x]
39 Hansen KE,Johnson MG.An update on vitamin D for clinicians.Curr Opin Endocrinol Diabetes Obes 2016;23:440-444[PMID:27653000 DOI:10.1097/MED.0000000000000288]
40 Stokes CS,Volmer DA,Grünhage F,Lammert F.Vitamin D in chronic liver disease.Liver Int 2013;33:338-352[PMID:23402606DOI:10.1111/liv.12106]
41 Lim LY,Chalasani N.Vitamin d deficiency in patients with chronic liver disease and cirrhosis.Curr Gastroenterol Rep 2012;14:67-73[PMID:22113744 DOI:10.1007/s11894-011-0231-7]
42 Targher G,Byrne CD.Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases:is there a causal link?Endocrine2014;47:3-4[PMID:24595898 DOI:10.1007/s12020-014-0220-3]
43 Stokes CS,Krawczyk M,Reichel C,Lammert F,Grünhage F.Vitamin D deficiency is associated with mortality in patients with advanced liver cirrhosis.Eur J Clin Invest 2014;44:176-183[PMID:24236541 DOI:10.1111/eci.12205]
44 Paternostro R,Wagner D,Reiberger T,Mandorfer M,Schwarzer R,Ferlitsch M,Trauner M,Peck-Radosavljevic M,Ferlitsch A.Low 25-OH-vitamin D levels reflect hepatic dysfunction and are associated with mortality in patients with liver cirrhosis.Wien Klin Wochenschr 2017;129:8-15[PMID:27888359 DOI:10.1007/s00508-016-1127-1]
45 Putz-Bankuti C,Pilz S,Stojakovic T,Scharnagl H,Pieber TR,Trauner M,Obermayer-Pietsch B,Stauber RE.Association of 25-hydroxyvitamin D levels with liver dysfunction and mortality in chronic liver disease.Liver Int 2012;32:845-851[PMID:22222013DOI:10.1111/j.1478-3231.2011.02735.x]
46 Arteh J,Narra S,Nair S.Prevalence of vitamin D deficiency in chronic liver disease.Dig Dis Sci 2010;55:2624-2628[PMID:19960254 DOI:10.1007/s10620-009-1069-9]
47 Fisher L,Fisher A.Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease.Clin Gastroenterol Hepatol2007;5:513-520[PMID:17222588 DOI:10.1016/j.cgh.2006.10.015]
48 Jha AK,Jha SK,Kumar A,Dayal VM,Jha SK.Effect of replenishment of vitamin D on survival in patients with decompensated liver cirrhosis:A prospective study.World J Gastrointest Pathophysiol2017;8:133-141[PMID:28868183 DOI:10.4291/wjgp.v8.i3.133]
49 Kitson MT,Roberts SK.D-livering the message:the importance of vitamin D status in chronic liver disease.J Hepatol 2012;57:897-909[PMID:22634121 DOI:10.1016/j.jhep.2012.04.033]
50 Reese PP,Bloom RD,Feldman HI,Huverserian A,Thomasson A,Shults J,Hamano T,Goral S,Shaked A,Olthoff K,Rickels MR,Bleicher M,Leonard MB.Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation.Liver Int 2012;32:287-296[PMID:22098635 DOI:10.1111/j.1478-3231.2011.02638.x]
51 Skaaby T,Husemoen LL,Borglykke A,J?rgensen T,Thuesen BH,Pisinger C,Schmidt LE,Linneberg A.Vitamin D status,liver enzymes,and incident liver disease and mortality:a general population study.Endocrine 2014;47:213-220[PMID:24272594DOI:10.1007/s12020-013-0107-8]
52 Wang JB,Abnet CC,Chen W,Dawsey SM,Fan JH,Yin LY,Yin J,Major JM,Taylor PR,Qiao YL,Freedman ND.Association between serum 25(OH)vitamin D,incident liver cancer and chronic liver disease mortality in the Linxian Nutrition Intervention Trials:a nested case-control study.Br J Cancer 2013;109:1997-2004[PMID:24008664 DOI:10.1038/bjc.2013.546]
53 Wortsman J,Matsuoka LY,Chen TC,Lu Z,Holick MF.Decreased bioavailability of vitamin D in obesity.Am J Clin Nutr 2000;72:690-693[PMID:10966885 DOI:10.1093/ajcn/72.3.690]
54 Stein EM,Strain G,Sinha N,Ortiz D,Pomp A,Dakin G,Mc Mahon DJ,Bockman R,Silverberg SJ.Vitamin D insufficiency prior to bariatric surgery:risk factors and a pilot treatment study.Clin Endocrinol(Oxf)2009;71:176-183[PMID:19018785 DOI:10.1111/j.1365-2265.2008.03470.x]
55 Chiu KC,Chu A,Go VL,Saad MF.Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction.Am J Clin Nutr 2004;79:820-825[PMID:15113720 DOI:10.1093/ajcn/79.5.820]
56 Ganji V,Zhang X,Shaikh N,Tangpricha V.Serum 25-hydroxyvitamin D concentrations are associated with prevalence of metabolic syndrome and various cardiometabolic risk factors in US children and adolescents based on assay-adjusted serum 25-hydroxyvitamin D data from NHANES 2001-2006.Am J Clin Nutr 2011;94:225-233[PMID:21613551 DOI:10.3945/ajcn.111.013516]
57 Barchetta I,De Bernardinis M,Capoccia D,Baroni MG,Fontana M,Fraioli A,Morini S,Leonetti F,Cavallo MG.Hypovitaminosis D is independently associated with metabolic syndrome in obese patients.PLo S One 2013;8:e68689[PMID:23935881 DOI:10.1371/journal.pone.0068689]
58 Shankar A,Sabanayagam C,Kalidindi S.Serum 25-hydroxyvitamin d levels and prediabetes among subjects free of diabetes.Diabetes Care 2011;34:1114-1119[PMID:21430085 DOI:10.2337/dc10-1203]
59 Knekt P,Laaksonen M,Mattila C,H?rk?nen T,Marniemi J,Heli?vaara M,Rissanen H,Montonen J,Reunanen A.Serum vitamin D and subsequent occurrence of type 2 diabetes.Epidemiology 2008;19:666-671[PMID:18496468 DOI:10.1097/EDE.0b013e318176b8ad]
60 Kayaniyil S,Retnakaran R,Harris SB,Vieth R,Knight JA,Gerstein HC,Perkins BA,Zinman B,Hanley AJ.Prospective associations of vitamin D withβ-cell function and glycemia:the PROspective Metabolism and ISlet cell Evaluation(PROMISE)cohort study.Diabetes 2011;60:2947-2953[PMID:21911752 DOI:10.2337/db11-0465]
61 Grimnes G,Emaus N,Joakimsen RM,Figenschau Y,Jenssen T,Nj?lstad I,Schirmer H,Jorde R.Baseline serum 25-hydroxyvitamin D concentrations in the Troms?Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up.Diabet Med 2010;27:1107-1115[PMID:20854377 DOI:10.1111/j.1464-5491.2010.03092.x]
62 Lamendola CA,Ariel D,Feldman D,Reaven GM.Relations between obesity,insulin resistance,and 25-hydroxyvitamin D.Am J Clin Nutr 2012;95:1055-1059[PMID:22440850 DOI:10.3945/ajcn.111.032060]
63 Rajakumar K,de las Heras J,Lee S,Holick MF,Arslanian SA.25-hydroxyvitamin D concentrations and in vivo insulin sensitivity andβ-cell function relative to insulin sensitivity in black and white youth.Diabetes Care 2012;35:627-633[PMID:22238280 DOI:10.2337/dc11-1825]
64 Targher G,Bertolini L,Scala L,Cigolini M,Zenari L,Falezza G,Arcaro G.Associations between serum 25-hydroxyvitamin D3concentrations and liver histology in patients with non-alcoholic fatty liver disease.Nutr Metab Cardiovasc Dis 2007;17:517-524[PMID:16928437 DOI:10.1016/j.numecd.2006.04.002]
65 Dasarathy J,Periyalwar P,Allampati S,Bhinder V,Hawkins C,Brandt P,Khiyami A,McCullough AJ,Dasarathy S..Hypovitaminosis D is associated with increased whole body fat mass and greater severity of non-alcoholic fatty liver disease.Liver Int2014;34:e118-e127[PMID:24118743 DOI:10.1111/liv.12312]
66 Jablonski KL,Jovanovich A,Holmen J,Targher G,Mc Fann K,Kendrick J,Chonchol M.Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.Nutr Metab Cardiovasc Dis 2013;23:792-798[PMID:23415456 DOI:10.1016/j.numecd.2012.12.006]
67 Barchetta I,Angelico F,Del Ben M,Baroni MG,Pozzilli P,Morini S,Cavallo MG.Strong association between non alcoholic fatty liver disease(NAFLD)and low 25(OH)vitamin D levels in an adult population with normal serum liver enzymes.BMC Med 2011;9:85[PMID:21749681 DOI:10.1186/1741-7015-9-85]
68 Nelson JE,Roth CL,Wilson LA,Yates KP,Aouizerat B,MorganStevenson V,Whalen E,Hoofnagle A,Mason M,Gersuk V,Yeh MM,Kowdley KV.Vitamin D Deficiency Is Associated With Increased Risk of Non-alcoholic Steatohepatitis in Adults With Nonalcoholic Fatty Liver Disease:Possible Role for MAPK and NF-κB?Am J Gastroenterol 2016;111:852-863[PMID:27002799 DOI:10.1038/ajg.2016.51]
69 Bril F,Maximos M,Portillo-Sanchez P,Biernacki D,Lomonaco R,Subbarayan S,Correa M,Lo M,Suman A,Cusi K.Relationship of vitamin D with insulin resistance and disease severity in nonalcoholic steatohepatitis.J Hepatol 2015;62:405-411[PMID:25195551 DOI:10.1016/j.jhep.2014.08.040]
70 European Association for the Study of the Liver.EASL Clinical Practice Guidelines:management of cholestatic liver diseases.J Hepatol 2009;51:237-267[PMID:19501929 DOI:10.1016/j.jhep.2009.04.009]
71 Leslie WD,Bernstein CN,Leboff MS;American Gastroenterological Association Clinical Practice Commitee.AGA technical review on osteoporosis in hepatic disorders.Gastroenterology 2003;125:941-966[PMID:12949738 DOI:10.1016/S0016-5085(03)01062-X]
72 Barchetta I,Cimini FA,Cavallo MG.Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease:Present and Future.Nutrients 2017;9:[PMID:28906453 DOI:10.3390/nu9091015]
73 Kitson MT,Pham A,Gordon A,Kemp W,Roberts SK.High-dose vitamin D supplementation and liver histology in NASH.Gut 2016;65:717-718[PMID:26294696 DOI:10.1136/gutjnl-2015-310417]
74 Barchetta I,Del Ben M,Angelico F,Di Martino M,Fraioli A,La Torre G,Saulle R,Perri L,Morini S,Tiberti C,Bertoccini L,Cimini FA,Panimolle F,Catalano C,Baroni MG,Cavallo MG.No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes:a randomized,double-blind,placebo-controlled trial.BMC Med 2016;14:92[PMID:27353492DOI:10.1186/s12916-016-0638-y]
75 Nagpal J,Pande JN,Bhartia A.A double-blind,randomized,placebo-controlled trial of the short-term effect of vitamin D3supplementation on insulin sensitivity in apparently healthy,middleaged,centrally obese men.Diabet Med 2009;26:19-27[PMID:19125756 DOI:10.1111/j.1464-5491.2008.02636.x]
76 von Hurst PR,Stonehouse W,Coad J.Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient-a randomised,placebo-controlled trial.Br J Nutr 2010;103:549-555[PMID:19781131 DOI:10.1017/S0007114509992017]
77 Pittas AG,Dawson-Hughes B,Li T,Van Dam RM,Willett WC,Manson JE,Hu FB.Vitamin D and calcium intake in relation to type 2 diabetes in women.Diabetes Care 2006;29:650-656[PMID:16505521 DOI:10.2337/diacare.29.03.06.dc05-1961]
78 Stokes CS,Grünhage F,Baus C,Volmer DA,Wagenpfeil S,Riemenschneider M,Lammert F.Vitamin D supplementation reduces depressive symptoms in patients with chronic liver disease.Clin Nutr 2016;35:950-957[PMID:26212170 DOI:10.1016/j.clnu.2015.07.004]
79 Bitetto D,Fabris C,Falleti E,Fornasiere E,Fumolo E,Fontanini E,Cussigh A,Occhino G,Baccarani U,Pirisi M,Toniutto P.Vitamin D and the risk of acute allograft rejection following human liver transplantation.Liver Int 2010;30:417-444[PMID:19849776 DOI:10.1111/j.1478-3231.2009.02154.x]
80 Bjelakovic G,Nikolova D,Bjelakovic M,Gluud C.Vitamin Dsupplementation for chronic liver diseases in adults.Cochrane Database Syst Rev 2017;11:CD011564[PMID:29099543 DOI:10.1002/14651858.CD011564.pub2]
81 Collier JD,Ninkovic M,Compston JE.Guidelines on the management of osteoporosis associated with chronic liver disease.Gut 2002;50 Suppl 1:i1-i9[PMID:11788576 DOI:10.1136/gut.50.suppl_1.i1]
82 Dasarathy J,Varghese R,Feldman A,Khiyami A,Mc Cullough AJ,Dasarathy S.Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.J Nutr 2017;147:1938-1946[PMID:28814531 DOI:10.3945/jn.117.254292]
83 Parola M,Leonarduzzi G,Biasi F,Albano E,Biocca ME,Poli G,Dianzani MU.Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis.Hepatology 1992;16:1014-1021[PMID:1398481 DOI:10.1002/hep.1840160426]
84 Houglum K,Venkataramani A,Lyche K,Chojkier M.A pilot study of the effects of d-alpha-tocopherol on hepatic stellate cell activation in chronic hepatitis C.Gastroenterology 1997;113:1069-1073[PMID:9322499 DOI:10.1053/gast.1997.v113.pm9322499]
85 Sanyal AJ,Chalasani N,Kowdley KV,Mc Cullough A,Diehl AM,Bass NM,Neuschwander-Tetri BA,Lavine JE,Tonascia J,Unalp A,Van Natta M,Clark J,Brunt EM,Kleiner DE,Hoofnagle JH,Robuck PR;NASH CRN.Pioglitazone,vitamin E,or placebo for nonalcoholic steatohepatitis.N Engl J Med 2010;362:1675-1685[PMID:20427778 DOI:10.1056/NEJMoa0907929]
86 Chalasani N,Younossi Z,Lavine JE,Charlton M,Cusi K,Rinella M,Harrison SA,Brunt EM,Sanyal AJ.The diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the Study of Liver Diseases.Hepatology2018;67:328-357[PMID:28714183 DOI:10.1002/hep.29367]
87 Mu?oz SJ,Heubi JE,Balistreri WF,Maddrey WC.Vitamin E deficiency in primary biliary cirrhosis:gastrointestinal malabsorption,frequency and relationship to other lipid-soluble vitamins.Hepatology 1989;9:525-531[PMID:2925155 DOI:10.1002/hep.1840090403]
88 Jeffrey GP,Muller DP,Burroughs AK,Matthews S,Kemp C,Epstein O,Metcalfe TA,Southam E,Tazir-Melboucy M,Thomas PK.Vitamin E deficiency and its clinical significance in adults with primary biliary cirrhosis and other forms of chronic liver disease.J Hepatol 1987;4:307-317[PMID:3036938 DOI:10.1016/S0168-8278(87)80539-1]
89 Leo MA,Rosman AS,Lieber CS.Differential depletion of carotenoids and tocopherol in liver disease.Hepatology 1993;17:977-986[PMID:8514270 DOI:10.1002/hep.1840170606]
90 Grüngreiff K,Reinhold D,Wedemeyer H.The role of zinc in liver cirrhosis.Ann Hepatol 2016;15:7-16[PMID:26626635 DOI:10.5604/16652681.1184191]
91 Ma J,Betts NM.Zinc and copper intakes and their major food sources for older adults in the 1994-96 continuing survey of food intakes by individuals(CSFII).J Nutr 2000;130:2838-2843[PMID:11053529 DOI:10.1093/jn/130.11.2838]
92 Huskisson E,Maggini S,Ruf M.The role of vitamins and minerals in energy metabolism and well-being.J Int Med Res 2007;35:277-289[PMID:17593855 DOI:10.1177/147323000703500301]
93 Gibson RS,King JC,Lowe N.A Review of Dietary Zinc Recommendations.Food Nutr Bull 2016;37:443-460[PMID:27312357 DOI:10.1177/0379572116652252]
94 Himoto T,Masaki T.Associations between Zinc Deficiency and Metabolic Abnormalities in Patients with Chronic Liver Disease.Nutrients 2018;10:[PMID:29342898 DOI:10.3390/nu10010088]
95 Chiba M,Katayama K,Takeda R,Morita R,Iwahashi K,Onishi Y,Kita H,Nishio A,Kanno T,Saito T,Maeda K,Naito M,Michida T,Ito T.Diuretics aggravate zinc deficiency in patients with liver cirrhosis by increasing zinc excretion in urine.Hepatol Res 2013;43:365-373[PMID:22994500 DOI:10.1111/j.1872-034X.2012.01093.x]
96 Nusrat S,Khan MS,Fazili J,Madhoun MF.Cirrhosis and its complications:evidence based treatment.World J Gastroenterol2014;20:5442-5460[PMID:24833875 DOI:10.3748/wjg.v20.i18.5442]
97 Van der Rijt CC,Schalm SW,Schat H,Foeken K,De Jong G.Overt hepatic encephalopathy precipitated by zinc deficiency.Gastroenterology 1991;100:1114-1118[PMID:2001810 DOI:10.1016/0016-5085(91)90290-2]
98 Rabbani P,Prasad AS.Plasma ammonia and liver ornithine transcarbamoylase activity in zinc-deficient rats.Am J Physiol 1978; 235:E203-E206 [PMID: 686166 DOI: 10.1152/ajpendo.1978.235.2.E203]
99 Katayama K,Saito M,Kawaguchi T,Endo R,Sawara K,Nishiguchi S,Kato A,Kohgo H,Suzuki K,Sakaida I,Ueno Y,Habu D,Ito T,Moriwaki H,Suzuki K.Effect of zinc on liver cirrhosis with hyperammonemia:a preliminary randomized,placebo-controlled double-blind trial.Nutrition 2014;30:1409-1414[PMID:25280421DOI:10.1016/j.nut.2014.04.018]
100 Marchesini G,Fabbri A,Bianchi G,Brizi M,Zoli M.Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.Hepatology 1996;23:1084-1092[PMID:8621138 DOI:10.1053/jhep.1996.v23.pm0008621138]
101 Takuma Y,Nouso K,Makino Y,Hayashi M,Takahashi H.Clinical trial:oral zinc in hepatic encephalopathy.Aliment Pharmacol Ther 2010;32:1080-1090[PMID:20822500 DOI:10.1111/j.1365-2036.2010.04448.x]
102 Mousa N,Abdel-Razik A,Zaher A,Hamed M,Shiha G,Effat N,Elbaz S,Elhelaly R,Hafez M,El-Wakeel N,Eldars W.The role of antioxidants and zinc in minimal hepatic encephalopathy:a randomized trial.Therap Adv Gastroenterol 2016;9:684-691[PMID:27582881 DOI:10.1177/1756283X16645049]
103 Mohammad MK,Zhou Z,Cave M,Barve A,Mc Clain CJ.Zinc and liver disease.Nutr Clin Pract 2012;27:8-20[PMID:22307488DOI:10.1177/0884533611433534]
104 Tabibian JH,Gerstenblith MR,Tedford RJ,Junkins-Hopkins JM,Abuav R.Necrolytic acral erythema as a cutaneous marker of hepatitis C:report of two cases and review.Dig Dis Sci 2010;55:2735-2743[PMID:20499177 DOI:10.1007/s10620-010-1273-7]
105 Pimentel CF,Lai M.Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease.Med Clin North Am 2016;100:1303-1327[PMID:27745596 DOI:10.1016/j.mcna.2016.06.010]
106 Tandon P,Raman M,Mourtzakis M,Merli M.A practical approach to nutritional screening and assessment in cirrhosis.Hepatology2017;65:1044-1057[PMID:28027577 DOI:10.1002/hep.29003]
107 Romani AM.Magnesium homeostasis and alcohol consumption.Magnes Res 2008;21:197-204[PMID:19271417]
108 Cohen L.Magnesium and liver cirrhosis:a hypothesis.Magnesium1985;4:1-4[PMID:4033201]
109 Raheli?D,Kujundzi?M,Romi?Z,Brki?K,Petrovecki M.Serum concentration of zinc,copper,manganese and magnesium in patients with liver cirrhosis.Coll Antropol 2006;30:523-528[PMID:17058518]
110 Agarwal A,Avarebeel S,Choudhary NS,Goudar M,Tejaswini CJ.Correlation of Trace Elements in Patients of Chronic Liver Disease with Respect to Child-Turcotte-Pugh Scoring System.J Clin Diagn Res 2017;11:OC25-OC28[PMID:29207755 DOI:10.7860/JCDR/2017/26519.10655]
111 Kar K,Dasgupta A,Vijaya Bhaskar M,Sudhakar K.Alteration of micronutrient status in compensated and decompensated liver cirrhosis.Indian J Clin Biochem 2014;29:232-237[PMID:24757308 DOI:10.1007/s12291-013-0349-5]
112 Nangliya V,Sharma A,Yadav D,Sunder S,Nijhawan S,Mishra S.Study of trace elements in liver cirrhosis patients and their role in prognosis of disease.Biol Trace Elem Res 2015;165:35-40[PMID:25613584 DOI:10.1007/s12011-015-0237-3]
113 Koivisto M,Valta P,H?ckerstedt K,Lindgren L.Magnesium depletion in chronic terminal liver cirrhosis.Clin Transplant 2002;16:325-328[PMID:12225427 DOI:10.1034/j.1399-0012.2002.01141.x]
114 Chao A,Waitzberg D,de Jesus RP,Bueno AA,Kha V,Allen K,Kappus M,Medici V.Malnutrition and Nutritional Support in Alcoholic Liver Disease:a Review.Curr Gastroenterol Rep 2016;18:65[PMID:27787787 DOI:10.1007/s11894-016-0539-4]
115 O'Shea RS,Dasarathy S,Mc Cullough AJ;Practice Guideline Committee of the American Association for the Study of Liver Diseases;Practice Parameters Committee of the American College of Gastroenterology.Alcoholic liver disease.Hepatology 2010;51:307-328[PMID:20034030 DOI:10.1002/hep.23258]
116 Rossi RE,Conte D,Massironi S.Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease:Overview of available evidence and open issues.Dig Liver Dis 2015;47:819-825[PMID:26164399 DOI:10.1016/j.dld.2015.05.021]
117 Amodio P,Bemeur C,Butterworth R,Cordoba J,Kato A,Montagnese S,Uribe M,Vilstrup H,Morgan MY.The nutritional management of hepatic encephalopathy in patients with cirrhosis:International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus.Hepatology 2013;58:325-336[PMID:23471642 DOI:10.1002/hep.26370]
118 Merli M,Giusto M,Lucidi C,Giannelli V,Pentassuglio I,Di Gregorio V,Lattanzi B,Riggio O.Muscle depletion increases the risk of overt and minimal hepatic encephalopathy:results of a prospective study.Metab Brain Dis 2013;28:281-284[PMID:23224378 DOI:10.1007/s11011-012-9365-z]
119 Plauth M,Merli M,Kondrup J,Weimann A,Ferenci P,Müller MJ;ESPEN Consensus Group.ESPEN guidelines for nutrition in liver disease and transplantation.Clin Nutr 1997;16:43-55[PMID:16844569 DOI:10.1016/S0261-5614(97)80022-2]
120 Plauth M,CabréE,Riggio O,Assis-Camilo M,Pirlich M,Kondrup J;DGEM(German Society for Nutritional Medicine),Ferenci P,Holm E,Vom Dahl S,Müller MJ,Nolte W;ESPEN(European Society for Parenteral and Enteral Nutrition).ESPEN Guidelines on Enteral Nutrition:Liver disease.Clin Nutr 2006;25:285-294[PMID:16707194 DOI:10.1016/j.clnu.2006.01.018]
121 Córdoba J,López-Hellín J,Planas M,Sabín P,Sanpedro F,Castro F,Esteban R,Guardia J.Normal protein diet for episodic hepatic encephalopathy:results of a randomized study.J Hepatol 2004;41:38-43[PMID:15246205 DOI:10.1016/j.jhep.2004.03.023]
122 BESSMAN AN,MIRICK GS.Blood ammonia levels following the ingestion of casein and whole blood.J Clin Invest 1958;37:990-998[PMID:13563627 DOI:10.1172/JCI103695]
123 Fenton JC,Knight EJ,Humpherson PL.Milk-and-cheese diet in portal-systemic encephalopathy.Lancet 1966;1:164-166[PMID:4159095 DOI:10.1016/S0140-6736(66)90696-9]
124 Greenberger NJ,Carley J,Schenker S,Bettinger I,Stamnes C,Beyer P.Effect of vegetable and animal protein diets in chronic hepatic encephalopathy.Am J Dig Dis 1977;22:845-855[PMID:335882 DOI:10.1007/BF01076158]
125 Gheorghe L,Iacob R,V?dan R,Iacob S,Gheorghe C.Improvement of hepatic encephalopathy using a modified high-calorie high-protein diet.Rom J Gastroenterol 2005;14:231-238[PMID:16200232]
126 Uribe M,Dibildox M,Malpica S,Guillermo E,Villallobos A,Nieto L,Vargas F,Garcia Ramos G.Beneficial effect of vegetable protein diet supplemented with psyllium plantago in patients with hepatic encephalopathy and diabetes mellitus.Gastroenterology 1985;88:901-907[PMID:2982694 DOI:10.1016/S0016-5085(85)80006-8]
127 Weber FL Jr,Minco D,Fresard KM,Banwell JG.Effects of vegetable diets on nitrogen metabolism in cirrhotic subjects.Gastroenterology 1985;89:538-544[PMID:2991068 DOI:10.1016/0016-5085(85)90448-2]
128 Uribe M,Márquez MA,Garcia Ramos G,Ramos-Uribe MH,Vargas F,Villalobos A,Ramos C.Treatment of chronic portal--systemic encephalopathy with vegetable and animal protein diets.Acontrolled crossover study.Dig Dis Sci 1982;27:1109-1116[PMID:6756833 DOI:10.1007/BF01391449]
129 Shekib LA,Zoueil ME,Youssef MM,Mohamed SW.Amino acid composition and In Vitro digestibility of lentil and rice proteins and their mixture(Koshary).Food Chem 1986;20:61-67[DOI:10.1016/0308-8146(86)90167-6]
130 Silk DB.Branched chain amino acids in liver disease:fact or fantasy?Gut 1986;27 Suppl 1:103-110[PMID:3098636 DOI:10.1136/gut.27.Suppl_1.103]
131 Fischer JE,Baldessarini RJ.False neurotransmitters and hepatic failure.Lancet 1971;2:75-80[PMID:4103986 DOI:10.1016/S0140-6736(71)92048-4]
132 Dam G,Ott P,Aagaard NK,Vilstrup H.Branched-chain amino acids and muscle ammonia detoxification in cirrhosis.Metab Brain Dis 2013;28:217-220[PMID:23315357 DOI:10.1007/s11011-013-9377-3]
133 Gluud LL,Dam G,Les I,Marchesini G,Borre M,Aagaard NK,Vilstrup H.Branched-chain amino acids for people with hepatic encephalopathy.Cochrane Database Syst Rev 2017;5:CD001939[PMID:28518283 DOI:10.1002/14651858.CD001939.pub4]
134 NCD Risk Factor Collaboration(NCD-Ris C).Trends in adult body-mass index in 200 countries from 1975 to 2014:a pooled analysis of 1698 population-based measurement studies with 19·2million participants.Lancet 2016;387:1377-1396[PMID:27115820DOI:10.1016/S0140-6736(16)30054-X]
135 Angrisani L,Santonicola A,Iovino P,Formisano G,Buchwald H,Scopinaro N.Bariatric Surgery Worldwide 2013.Obes Surg2015;25:1822-1832[PMID:25835983 DOI:10.1007/s11695-015-1657-z]
136 Diehl AM,Day C.Cause,Pathogenesis,and Treatment of Nonalcoholic Steatohepatitis.N Engl J Med 2017;377:2063-2072[PMID:29166236 DOI:10.1056/NEJMra1503519]
137 Angulo P,Kleiner DE,Dam-Larsen S,Adams LA,Bjornsson ES,Charatcharoenwitthaya P,Mills PR,Keach JC,Lafferty HD,Stahler A,Haflidadottir S,Bendtsen F.Liver Fibrosis,but No Other Histologic Features,Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.Gastroenterology 2015;149:389-97.e10[PMID:25935633 DOI:10.1053/j.gastro.2015.04.043]
138 Ekstedt M,Hagstr?m H,Nasr P,Fredrikson M,St?l P,Kechagias S,Hultcrantz R.Fibrosis stage is the strongest predictor for diseasespecific mortality in NAFLD after up to 33 years of follow-up.Hepatology 2015;61:1547-1554[PMID:25125077 DOI:10.1002/hep.27368]
139 Bhaskaran K,Douglas I,Forbes H,dos-Santos-Silva I,Leon DA,Smeeth L.Body-mass index and risk of 22 specific cancers:a population-based cohort study of 5·24 million UK adults.Lancet 2014;384:755-765[PMID:25129328 DOI:10.1016/S0140-6736(14)60892-8]
140 Watt KD.Reducing the load:the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation.Liver Transpl 2012;18 Suppl 2:S52-S58[PMID:22821716 DOI:10.1002/lt.23515]
141 Iannelli A.Bariatric surgery and liver transplant.Liver Transpl2017;23:1369-1370[PMID:28945954 DOI:10.1002/lt.24948]
142 Saab S,Lalezari D,Pruthi P,Alper T,Tong MJ.The impact of obesity on patient survival in liver transplant recipients:a meta-analysis.Liver Int 2015;35:164-170[PMID:24313970 DOI:10.1111/liv.12431]
143 Perez-Protto SE,Quintini C,Reynolds LF,You J,Cywinski JB,Sessler DI,Miller C.Comparable graft and patient survival in lean and obese liver transplant recipients.Liver Transpl 2013;19:907-915[PMID:23744721 DOI:10.1002/lt.23680]
144 Karagozian R,Bhardwaj G,Wakefield DB,Baffy G.Obesity paradox in advanced liver disease:obesity is associated with lower mortality in hospitalized patients with cirrhosis.Liver Int 2016;36:1450-1456[PMID:27037497 DOI:10.1111/liv.13137]
145 Terjimanian MN,Harbaugh CM,Hussain A,Olugbade KO Jr,Waits SA,Wang SC,Sonnenday CJ,Englesbe MJ.Abdominal adiposity,body composition and survival after liver transplantation.Clin Transplant 2016;30:289-294[PMID:26717257 DOI:10.1111/ctr.12688]
146 Hamaguchi Y,Kaido T,Okumura S,Kobayashi A,Shirai H,Yagi S,Kamo N,Okajima H,Uemoto S.Impact of Skeletal Muscle Mass Index,Intramuscular Adipose Tissue Content,and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.Transplantation 2017;101:565-574[PMID:27926595 DOI:10.1097/TP.0000000000001587]
147 Lazzati A,Iannelli A,Schneck AS,Nelson AC,Katsahian S,Gugenheim J,Azoulay D.Bariatric surgery and liver transplantation:a systematic review a new frontier for bariatric surgery.Obes Surg 2015;25:134-142[PMID:25337867 DOI:10.1007/s11695-014-1430-8]
148 Mosko JD,Nguyen GC.Increased perioperative mortality following bariatric surgery among patients with cirrhosis.Clin Gastroenterol Hepatol 2011;9:897-901[PMID:21782772 DOI:10.1016/j.cgh.2011.07.007]
149 Duvoux C,Roudot-Thoraval F,Decaens T,Pessione F,Badran H,Piardi T,Francoz C,Compagnon P,Vanlemmens C,Dumortier J,Dharancy S,Gugenheim J,Bernard PH,Adam R,Radenne S,Muscari F,Conti F,Hardwigsen J,Pageaux GP,Chazouillères O,Salame E,Hilleret MN,Lebray P,Abergel A,Debette-Gratien M,Kluger MD,Mallat A,Azoulay D,Cherqui D;Liver Transplantation French Study Group.Liver transplantation for hepatocellular carcinoma:a model includingα-fetoprotein improves the performance of Milan criteria.Gastroenterology 2012;143:986-94.e3;quiz e14-5[PMID:22750200DOI:10.1053/j.gastro.2012.05.052]
150 Mazzaferro V,Sposito C,Zhou J,Pinna AD,De Carlis L,Fan J,Cescon M,Di Sandro S,Yi-Feng H,Lauterio A,Bongini M,Cucchetti A.Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma.Gastroenterology 2018;154:128-139[PMID:28989060 DOI:10.1053/j.gastro.2017.09.025]
151 Al-Nowaylati AR,Al-Haddad BJ,Dorman RB,Alsaied OA,Lake JR,Chinnakotla S,Slusarek BM,Sampson BK,Ikramuddin S,Buchwald H,Leslie DB.Gastric bypass after liver transplantation.Liver Transpl2013;19:1324-1329[PMID:24039124 DOI:10.1002/lt.23734]
152 Heimbach JK,Watt KD,Poterucha JJ,Ziller NF,Cecco SD,Charlton MR,Hay JE,Wiesner RH,Sanchez W,Rosen CB,Swain JM.Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.Am J Transplant 2013;13:363-368[PMID:23137119 DOI:10.1111/j.1600-6143.2012.04318.x]
153 Prakash G,Drenick EJ,Wexler H,De Lucia L,Finegold SM.Microbial flora in the bypassed jejunum of patients with biliopancreatic bypass for obesity.Am J Clin Nutr 1987;46:273-276[PMID:3618530 DOI:10.1093/ajcn/46.2.273]
154 D'Albuquerque LA,Gonzalez AM,Wahle RC,de Oliveira Souza E,Mancero JM,de Oliveira e Silva A.Liver transplantation for subacute hepatocellular failure due to massive steatohepatitis after bariatric surgery.Liver Transpl 2008;14:881-885[PMID:18508357DOI:10.1002/lt.21472]
155 Rogers CC,Alloway RR,Alexander JW,Cardi M,Trofe J,Vinks AA.Pharmacokinetics of mycophenolic acid,tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients:a pilot study.Clin Transplant 2008;22:281-291[PMID:18482049 DOI:10.1111/j.1399-0012.2007.00783.x]
156 Clapp B,Wynn M,Martyn C,Foster C,O’Dell M,Tyroch A.Long term(7 or more years)outcomes of the sleeve gastrectomy:a metaanalysis.Surg Obes Relat Dis 2018;14:741-747[PMID:29625744DOI:10.1016/j.soard.2018.02.027]
157 Noel P,Nedelcu M,Eddbali I,Manos T,Gagner M.What are the long-term results 8 years after sleeve gastrectomy?Surg Obes Relat Dis 2017;13:1110-1115[PMID:28755888 DOI:10.1016/j.soard.2017.03.007]
158 Berger ER,Clements RH,Morton JM,Huffman KM,Wolfe BM,Nguyen NT,Ko CY,Hutter MM.The Impact of Different Surgical Techniques on Outcomes in Laparoscopic Sleeve Gastrectomies:The First Report from the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program(MBSAQIP).Ann Surg 2016;264:464-473[PMID:27433904 DOI:10.1097/SLA.0000000000001851]
159 Peterli R,W?lnerhanssen BK,Vetter D,Nett P,Gass M,Borbély Y,Peters T,Schiesser M,Schultes B,Beglinger C,Drewe J,Bueter M.Laparoscopic Sleeve Gastrectomy Versus Roux-Y-Gastric Bypass for Morbid Obesity-3-Year Outcomes of the Prospective Randomized Swiss Multicenter Bypass Or Sleeve Study(SM-BOSS).Ann Surg 2017;265:466-473[PMID:28170356 DOI:10.1097/SLA.0000000000001929]
160 Schneck AS,Anty R,Patouraux S,Bonnafous S,Rousseau D,Lebeaupin C,Bailly-Maitre B,Sans A,Tran A,Gugenheim J,Iannelli A,Gual P.Roux-En Y Gastric Bypass Results in LongTerm Remission of Hepatocyte Apoptosis and Hepatic Histological Features of Non-alcoholic Steatohepatitis.Front Physiol 2016;7:344[PMID:27594839 DOI:10.3389/fphys.2016.00344]
161 Geerts A,Darius T,Chapelle T,Roeyen G,Francque S,Libbrecht L,Nevens F,Pirenne J,Troisi R.The multicenter Belgian survey on liver transplantation for hepatocellular failure after bariatric surgery.Transplant Proc 2010;42:4395-4398[PMID:21168706 DOI:10.1016/j.transproceed.2010.07.010]
162 Sj?str?m L.Review of the key results from the Swedish Obese Subjects(SOS)trial-a prospective controlled intervention study of bariatric surgery.J Intern Med 2013;273:219-234[PMID:23163728 DOI:10.1111/joim.12012]
163 Adams TD,Davidson LE,Litwin SE,Kim J,Kolotkin RL,Nanjee MN,Gutierrez JM,Frogley SJ,Ibele AR,Brinton EA,Hopkins PN,Mc Kinlay R,Simper SC,Hunt SC.Weight and Metabolic Outcomes 12 Years after Gastric Bypass.N Engl J Med 2017;377:1143-1155[PMID:28930514 DOI:10.1056/NEJMoa1700459]
164 Safwan M,Collins KM,Abouljoud MS,Salgia R.Outcome of liver transplantation in patients with prior bariatric surgery.Liver Transpl2017;23:1415-1421[PMID:28752920 DOI:10.1002/lt.24832]
165 Shaheen O,Siejka J,Thatigotla B,Pham DT.A systematic review of portomesenteric vein thrombosis after sleeve gastrectomy.Surg Obes Relat Dis 2017;13:1422-1431[PMID:28526434 DOI:10.1016/j.soard.2017.03.015]